Skip to content
Research Article Open access CC BY 4.0

Primary Diagnostic Tools for SARS-CoV-2 Infection (COVID-19): Mini Review Based on Current Challenges in Molecular Techniques and Point of Care Testing for Screening

K. Kokilavani, Bindu Salim

International Journal of Pathogen Research · pp. 94–104 · Published 31 Dec 2020

10.9734/ijpr/2020/v5i430149

Abstract

Pandemic outbreaks are always a challenge for the health care management to control the mortality rate when the preventive measures are not established. The challenge is being faced worldwide with the outbreak of COVID-19 including the developed countries. The only solution is to control the spread by conducting massive screening and isolating affected ones from the healthy ones, which needs the development of screening methods that can reach the maximum population. The next step is to come up with vaccines. The research concentration worldwide is focussed on developing rapid diagnostics and screening at an affordable cost. Multiple studies suggest that Reverse Transcription- Polymerase Chain Reaction (RT-PCR), protein testing and Computed Tomography (CT) should be the principal diagnostic methods for routine testing/ screening in patients with COVID-19. But three factors are still indistinct in those diagnostic methods such as rapidity, sensitivity, and specificity. Thus, alternative approaches that provide higher efficiency and rapid are highly appreciated for the super spread infectious disease detection. Presently, microfluidics-based test kits alternatively called as lab-on-a-chip or Point- Of -Care Testing (POCT) have been widely used in cancer and viral detection. The ability of POCT tests to provide short time results, suitable in low resource clinics or even at home should be an attractive alternative. So, the miniaturized tools suitable for COVID-19 detection will replace the current expensive methods. Despite the limitations, the approved tests are still providing good results for this high risk pandemic. Many articles in the recent past highlighted the POCT method is not less than any other screening methods and by reviewing a wide research background, the importance of developing POCTs for screening such pandemic is presented here.

Diagnostics sensitivity and specificity COVID-19 POCT pandemic.

References (49)

  1. 1 A pneumonia outbreak associated with a new coronavirus of probable bat origin [DOI]
  2. 2 Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases [DOI]
  3. 3 Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR [DOI]
  4. 4 Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study [DOI]
  5. 5 Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19) [DOI]
  6. 6 CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV) [DOI]
  7. 7 Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study [DOI]
  8. 8 Coronavirus Disease 2019 (COVID-19): A Perspective from China [DOI]
  9. 9 Accelerated reaction by loop-mediated isothermal amplification using loop primers [DOI]
  10. 10 Chest CT for Typical Coronavirus Disease 2019 (COVID-19) Pneumonia: Relationship to Negative RT-PCR Testing [DOI]
  11. 11 Development and clinical application of a rapid IgM‐IgG combined antibody test for SARS‐CoV‐2 infection diagnosis [DOI]
  12. 12 Diagnosing COVID-19: The Disease and Tools for Detection [DOI]
  13. 13 Viral load of SARS-CoV-2 in clinical samples [DOI]
  14. 14 Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review [DOI]
  15. 15 Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia [DOI]
  16. 16 Real-time RT-PCR in COVID-19 detection: issues affecting the results [DOI]
  17. 17 Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies [DOI]
  18. 18 False Negative Tests for SARS-CoV-2 Infection — Challenges and Implications [DOI]
  19. 19 Genetic diversity and evolution of SARS-CoV-2 [DOI]
  20. 20 Recent advances and perspectives of nucleic acid detection for coronavirus [DOI]
  21. 21 Comparison of seven commercial RT-PCR diagnostic kits for COVID-19 [DOI]
  22. 22 Combination of RT‐qPCR testing and clinical features for diagnosis of COVID‐19 facilitates management of SARS‐CoV‐2 outbreak [DOI]
  23. 23 A smartphone dongle for diagnosis of infectious diseases at the point of care [DOI]
  24. 24 Developing antibody tests for SARS-CoV-2 [DOI]
  25. 25 Molecular diagnostic technologies for COVID-19: Limitations and challenges [DOI]
  26. 26 COVID-19 pneumonia: what has CT taught us? [DOI]
  27. 27 Real-Time Reverse Transcription–Polymerase Chain Reaction Assay for SARS-associated Coronavirus [DOI]
  28. 28 Taking connected mobile-health diagnostics of infectious diseases to the field [DOI]
  29. 29 SARS-CoV-2: virus dynamics and host response [DOI]
  30. 30 Patients with RT-PCR-confirmed COVID-19 and Normal Chest CT [DOI]
  31. 31 High-throughput screening by droplet microfluidics: perspective into key challenges and future prospects [DOI]
  32. 32 Advanced “lab-on-a-chip” to detect viruses – Current challenges and future perspectives [DOI]
  33. 33 Digital polymerase chain reaction technology – recent advances and future perspectives [DOI]
  34. 34 Smartphone-based multiplex 30-minute nucleic acid test of live virus from nasal swab extract [DOI]
  35. 35 Artificial intelligence to codify lung CT in Covid-19 patients [DOI]
  36. 36 Identification of an epitope of SARS-coronavirus nucleocapsid protein [DOI]
  37. 37 Multiplexed efficient on-chip sample preparation and sensitive amplification-free detection of Ebola virus [DOI]
  38. 38 Development of a fluorogenic RT-PCR assay (TaqMan) for the detection of Hendra virus [DOI]
  39. 39 Saliva as a Potential Diagnostic Specimen for COVID-19 Testing [DOI]
  40. 40 Microfluidic device for novel breast cancer screening by blood test using miRNA beacon probe [DOI]
  41. 41 Point-of-Care Microdevices for Blood Plasma Analysis in Viral Infectious Diseases [DOI]
  42. 42 The epidemiology and surveillance response to pandemic influenza A (H1N1) among local health departments in the San Francisco Bay Area [DOI]
  43. 43 Detection of Human Cytomegalovirus DNA by Real-Time Quantitative PCR [DOI]
  44. 44 PMMA Platform Based Micro Fluidic Mixer for the Detection of MicroRNA- 18a from Retinoblastoma Serum [DOI]
  45. 45 Assay Techniques and Test Development for COVID-19 Diagnosis [DOI]
  46. 46 Point-of-care testing for COVID-19 using SHERLOCK diagnostics [DOI]
  47. 47 SARS-CoV-2 specific antibody responses in COVID-19 patients [DOI]
  48. 48 Antibody responses to SARS-CoV-2 in COVID-19 patients: the perspective application of serological tests in clinical practice [DOI]
  49. 49 Rapid and extraction-free detection of SARS-CoV-2 from saliva with colorimetric LAMP [DOI]

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.